Abstract submission is now open! Send us your research through Jan. 26, 2024 to present at the 27th Annual Meeting.
Highlights in the second quarter of 2021 include the approval of a new gene therapy in Japan, the expansion of gene therapy approvals to three new countries, and more!
The second of a new, quarterly publication from ASGCT and Informa Pharma Intelligence, the Gene, Cell, & RNA Therapy Landscape report, is now available! It is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.
Highlights from the second issue include:
Read the Full Report
David M. Barrett, JD, MS is the Chief Executive Officer of the American Society of Gene & Cell Therapy.
May 7-11, 2024 | Baltimore, MD
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico